Dr Charles Shepherd reports briefly on the MEA website on the 2016 Invest in ME conference, which was held in London on Friday June 3. Hot topics included autoimmunity; big data – genomics, metabolomics, proteomics; biomarkers and sub-grouping; European and International collaboration, and rituximab.
“This was an interesting, encouraging and informative conference that covered a number of important new approaches to the way in which the investigation of the underlying disease process in ME/CFS, as well as the development of diagnostic biomarkers, is now moving forward. Hopefully, these developments will also lead to much needed treatments that are aimed at causation rather than symptoms control – as is currently the case.”
Also recommended is another comprehensive conference report from Mark
Berry.
The conference journal is available to download as a pdf
A DVD of the conference proceedings can be pre-ordered
